Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (Study ST000977)

Reversed phase NEGATIVE ION MODE/Eicosanoids (Analysis AN001598)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8
9_10-e-DiHO	ME240815	3.35	0.88	1.50	0.90	0.36	0.92	0.39	0.61
PGE2	ME240807	3.81	0.76	2.15	0.52	0.31	0.51	0.36	0.50
12-HETE	ME240833	5.28	0.03	3.83	0.30	0.01	0.02	0.01	0.02
TXB2	ME240805	4.23	0.16	4.50	0.51	0.08	0.14	0.07	0.12
11(12)-EpETrE	ME240846	NA	0.43	0.08	2.77	0.01	1.96	0.30	0.31
14(15)-EpETrE	ME240845	NA	NA	0.55	3.76	NA	1.93	0.08	0.06
4-HDoHE	ME240839	0.45	0.92	1.22	3.41	0.46	1.17	0.77	0.48
5-KETE	ME240854	0.84	0.79	0.53	4.41	0.36	0.89	0.60	0.65
12(13)-EpODE	ME240843	0.27	2.02	0.59	0.76	0.34	1.29	0.55	3.35
15-HETE	ME240832	2.07	0.71	2.56	1.63	0.37	0.70	0.32	0.81
17-HDoHE	ME240838	1.61	0.54	1.77	1.61	0.70	0.92	0.69	0.57
PGF2a	ME240808	1.13	0.36	2.36	1.21	1.35	0.32	0.68	1.68
Resolvin E1	ME240813	0.70	0.48	2.28	0.65	0.85	0.77	1.19	1.05
19(20)-EpDPE	ME240850	0.40	2.72	0.40	1.30	0.72	0.62	1.04	0.66
8(9)-EpETrE	ME240847	2.11	0.52	0.53	2.92	0.51	0.53	0.54	0.81
14_15-DiHETE	ME240826	1.01	0.70	1.09	2.30	1.01	0.70	0.69	1.03
17_18-DiHETE	ME240825	1.14	0.79	0.89	2.02	1.08	0.58	0.95	0.85
5-HETE	ME240835	1.14	1.52	0.66	2.21	0.61	1.17	0.38	0.98
5_6-DiHETrE	ME240824	1.01	0.99	0.67	2.53	0.61	0.77	0.89	1.04
9-HETE	ME240834	0.87	1.20	0.84	2.43	0.34	0.96	0.66	0.62
PGF2a EA	ME240811	0.21	1.59	NA	0.76	0.58	0.91	0.78	1.69
9-HEPE	ME240836	1.47	0.48	1.11	1.74	0.17	1.60	0.76	1.38
PGE1	ME240806	0.95	0.33	1.27	1.50	0.39	2.24	0.71	1.17
5_15-DiHETE	ME240814	0.87	0.32	1.12	0.93	0.32	1.31	1.29	1.70
17(18)-EpETE	ME240848	0.49	0.63	1.24	1.12	0.85	1.60	1.03	0.91
9-Nitrooleate	ME240856	0.80	0.63	1.27	0.86	0.44	1.72	0.84	0.95
11(12)-EpETE	ME240849	0.97	0.75	0.39	0.72	0.94	1.40	1.13	0.93
12(13)-Ep-9-KODE	ME240851	0.52	0.91	0.55	0.72	1.74	1.15	1.03	0.84
F2 IsoP	ME240809	0.82	0.83	1.07	1.04	0.99	1.15	0.73	1.74
5-HEPE	ME240837	0.40	1.08	0.58	1.61	1.33	1.08	0.71	1.28
13-KODE	ME240852	1.20	1.06	0.93	1.33	0.63	1.19	0.82	1.08
9-KODE	ME240853	0.96	1.13	1.26	1.57	0.63	1.08	0.72	1.07
15_16-DiHODE	ME240818	0.42	1.22	0.72	1.31	0.80	1.32	0.98	1.15
9(10)-EpODE	ME240844	0.41	1.19	0.77	1.30	0.58	1.66	0.83	1.18
15-Keto PGE2	ME240810	0.58	0.95	0.77	1.33	1.09	1.03	1.05	1.05
13-HOTE	ME240830	0.84	1.19	0.69	1.02	0.78	1.34	0.97	1.04
14_15-DiHETrE	ME240821	0.77	1.31	0.72	1.27	0.90	1.02	1.04	0.95
11_12-DiHETrE	ME240822	0.87	1.23	0.77	1.02	0.90	0.98	1.10	1.15
8_9-DiHETrE	ME240823	0.98	1.21	0.81	1.19	0.85	0.92	1.08	1.04
10-Nitrooleate	ME240855	1.24	0.67	1.18	0.84	1.02	0.78	1.30	0.76
19_20-DiHDoPA	ME240827	1.05	1.56	0.59	0.72	1.40	0.56	1.15	0.94
9_10-DiHODE	ME240820	0.28	1.57	0.33	1.46	0.50	2.17	0.43	1.13
12_13-DiHODE	ME240819	0.52	1.48	0.55	1.34	0.61	1.55	0.56	1.17
9(10)-EpOME	ME240841	0.38	1.37	0.42	1.31	0.71	1.92	0.52	1.38
12(13)-EpOME	ME240840	0.57	0.97	0.59	1.30	0.43	2.12	0.50	1.64
9_10-DiHOME	ME240817	0.43	1.18	0.37	1.08	0.61	2.32	0.58	1.07
9-HOTE	ME240831	0.56	0.97	0.61	1.19	0.75	1.88	0.67	1.21
13-HODE	ME240828	0.72	0.99	0.56	1.06	0.65	2.11	0.58	1.08
12_13-DiHOME	ME240816	0.62	1.16	0.52	1.30	0.55	1.98	0.67	1.04
9-HODE	ME240829	0.66	1.17	0.54	1.13	0.68	1.96	0.60	1.13
15(16)-EpODE	ME240842	0.42	1.09	0.92	0.95	0.52	1.67	0.63	2.21
Sum-TriHOME	ME240812	0.95	1.85	0.85	1.00	0.18	1.54	0.53	1.77

Factors:

F1	Ethnicity:Caucasian \| Gender:Female \| Group:Healthy Control
F2	Ethnicity:Caucasian \| Gender:Female \| Group:NAFLD
F3	Ethnicity:Caucasian \| Gender:Male \| Group:Healthy Control
F4	Ethnicity:Caucasian \| Gender:Male \| Group:NAFLD
F5	Ethnicity:Hispanic \| Gender:Female \| Group:Healthy Control
F6	Ethnicity:Hispanic \| Gender:Female \| Group:NAFLD
F7	Ethnicity:Hispanic \| Gender:Male \| Group:Healthy Control
F8	Ethnicity:Hispanic \| Gender:Male \| Group:NAFLD

Data matrix